MyCardium AI Featured in the Financial Times: Advancing the Frontiers of Cardiovascular Imaging

MyCardium AI has been featured in the Financial Times article, “AI start-ups make big gains in healthcare.” The feature highlights a new generation of innovators using artificial intelligence to accelerate clinical decision-making and improve patient outcomes across global healthcare systems.

As a spin-out from University College London (UCL), one of the world’s leading centres for cardiovascular research, MyCardium AI was founded with a mission to translate world-class academic science into clinically validated, real-world solutions. Our technology leverages advanced AI and deep learning to deliver accurate, reproducible cardiac imaging analysis, empowering clinicians, research organisations, and pharmaceutical partners to advance cardiovascular care with confidence.

This recognition from the Financial Times underscores both the scientific rigour and clinical relevance of our work. It also reflects the incredible foundation built through UCL’s ongoing support, collaboration, and belief in our vision to transform the future of cardiac diagnostics.

We remain committed to bridging the gap between academic excellence and scalable healthcare impact, ensuring every innovation contributes meaningfully to improved patient outcomes.

Read the full Financial Times article here >